Intellectual Property

Pharmaceutical Antitrust Consulting

J.S. Held’s Inaugural Global Risk Report Examines Potential Business Risks & Opportunities in 2024

Read More close Created with Sketch.

Ocean Tomo, a part of J.S. Held, delivers specialized expertise to assist pharmaceutical firms seeking to comply with FTC regulations and U.S. antitrust laws as they negotiate Hatch-Waxman-related agreements.

Visit Ocean Tomo for more information about J.S. Held's intellectual property services.

We provide financial and economic consulting services to both branded and generic firms based on the procedural position of either the Hatch-Waxman litigation or the ensuing antitrust action(s). Our team leverages our experience in valuing intangible assets and intellectual property to guide clients through legal proceedings including pre-Paragraph IV filing, crafting settlements, and defending deals in antitrust litigation.

Our Services
  • Economic & Financial Guidance Regarding Alleged Antitrust Violations
  • Fair Value Quantification
  • Financial & Economic Terms of Licenses Negotiations
Our Subject Matter Experts
  • Certified Licensing Professionals
  • Certified Public Accountants
  • Economists
  • Intellectual Property Valuation Experts
  • Testifying Experts
Featured Pharmaceutical Litigation Experience
  • Allergan, Inc. v. Sandoz, Inc., et. al.
  • Altana Pharma AG and Wyeth v. Teva Pharmaceuticals USA, Inc.
  • AstraZeneca AB et. al., v. Teva Pharmaceutical Industries Ltd., et. al.
  • Andrx Pharmaceuticals, LLC v. GlaxoSmithKline, PLC and SmithKline
  • Bayer Pharma AG, et. seq. v. Watson Laboratories, Inc.
  • Brian D. Zdeb, et. al. v. Baxter International, Inc.
  • Bristol-Myers Squibb Company v. Apotex Inc. and Apotex Corp.
  • Cephalon, Inc. v. Sun Pharmaceutical Industries, Inc., et. al.
  • Ferring Pharmaceuticals, Inc. v Serenity Pharmaceuticals LLC
  • Hoffman-LaRoche, Inc. v. Cobalt Pharmaceuticals, Inc.
  • Idenix Pharmaceuticals, Inc. v Gilead Sciences, Inc.
  • In Re Gabapentin Patent Litigation
  • King Pharmaceuticals v. Lupin Pharmaceuticals
  • Leo Pharma A/S v. Tolmar, Inc. et. al.
  • Lupin Pharmaceuticals v. Abbott Labs and Astellas Pharma, Inc.
  • Pfizer, Inc., et. seq. v. Purepac Pharmaceutical Co., et. al.
  • Pharmacia & Upjohn Company, LLC v. Sicor Pharmaceuticals, Inc.
  • Putney, Inc. v. Pfizer, Inc.
  • Tekmira Pharmaceuticals Corp. v. Alnylam Pharmaceuticals, Inc.
  • ViiV Healthcare UK, Ltd. v. Lupin Limited, et. al.
  • ViiV Healthcare UK, Ltd. v. Mylan Inc., et. al.
  • Wyeth Pharmaceuticals v. Anchen Pharmaceuticals
Keep up with the latest research and announcements from our team.
Our Experts